Cellenion and ECOBIO laboratory (UMR CNRS-University of Rennes) have received a Labcom-2020 €360k grant by the French National Research Agency (ANR) for the creation of the joint MICROSCALE-Lab (MICRObial Single Cell AnaLysEs Laboratory). The overall objective of this 5-year project is to offer a complete solution for the isolation, library preparation and bioinformatic analysis of […]

FLAMIN-GO Project Seeks to Develop Organ-on-a-Chip Technology for Clinical Trials in Rheumatoid Arthritis Therapy SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has joined the FLAMIN-GO Project consortium of academic and industry leaders in rheumatology, autoimmune disease […]

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS) PERTH, Australia — A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 […]

Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation software. CAMBRIDGE, UK: Optibrium Ltd and BioPharmics LLC, leading providers of software and computational solutions for drug discovery, today announce their partnership. The collaboration will combine industry-leading computational design solutions with advanced interactive user interfaces, engaging with experimental […]

InSphero and Hamilton Announce Collaboration to Improve the Production and Handling of Spheroids Using Advanced Liquid Handling Technology Both partners have a proven track record for being a successful entrepreneur and a technical disruptor at the intersection of 3D in vitro technologies and automation.  Schlieren, Switzerland – InSphero AG, the pioneer of 3D cell-based assay technology […]

New facility will provide end-to-end solution to accelerate cell therapy development and manufacturing WALTHAM, Mass. and SAN FRANCISCO — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. […]

IsoPlexis adds Switzerland as the latest country with access to their unique functional single-cell proteomics platform, adding to their existing partnerships across Asia and Europe. BRANFORD, Conn. — IsoPlexis, the leader in single-cell proteomics, today announced an exclusive agreement with Bucher Biotec AG, a Swiss distributor company representing some of the most advanced US, European, and […]

The deal will commercialize LightDeck’s environmental offering to ensure public safety in drinking, recreational, and agricultural water sources Boulder, CO. — LightDeck Diagnostics today announced its partnership with Hach, a global leader in water quality analysis and a subsidiary of Danaher to scale its proprietary environmental offering. As part of the commercial agreement, Hach will […]

The partnership brings together one of the world’s premier microscopy vendors and Akoya’s high-parameter CODEX® System for advancing the emerging field of spatial phenotyping and discovery MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that it has entered into an agreement with ZEISS to co-market Akoya’s CODEX® spatial phenotyping […]

Cytiva will provide products and services to the soon-to-be largest vaccine manufacturing and biopharmaceutical development center in Korea Cytiva and Prestige Biopharma have formed a collaboration to accelerate manufacturing COVID-19 vaccines and antibody therapies. With Cytiva’s cell culture and purification process products and services, Prestige will advance biopharmaceutical development, and rapidly and flexibly scale-up the […]